was just making notes while listening again to the
Post# of 36537
(Total Views: 136)
Posted On: 01/12/2019 11:03:21 AM
was just making notes while listening again to the interview....ignore if does not apply...
---Transformation, revenue generating assets
---up to date, explain the new business model
---jan 17, cleaned company, clean security structure
acquisitions, 2nd year....a+e....keytruda, shengzen (rights to china only)
viable company, inquisitional strategy....nugenerex distribution solutions....
names all....a lab, pharmacy network,mso, other assets
---grow to 24 more states, by year end, or 18 months
---billion dollar in revenue from veneto assets
---2 surgical businesses.....will move thru own own mso
---regenerative medicine companies, 2 olaregen, regentys
---olaregen...17 approved medical uses, sales will start in feb...
will move this product to our mso....
no longer a biotech....what is the business model
change of name is coming up down the pike
will acquire many other companies....some will close in the next couple of weeks
---revenue generating companies
veneto operation....how much in revenue?....explain...
pharmacy network....plus mso
terry anderson...medco original owner
i in Texas....working hard to make inroad into 27 more states
growth trajectory....yes he did say a 30 billion dollar venture (
generating right now....78,000,000 top line, 30 mill net....re configuring from a private to a public strategy....knee deep in building
expand to 30 states....goal....as many we can this year
can generate 1 billion per year in sales...
with pharmacy....no less than 1 billion
bottom line...100,000,000 ebitda at least
fantastic, highly profitable
other operations....picked up 2
olaregen...wound care company
17 fda approved types of wounds
ready to commercialize, will start feb...real sales, real $s
projections?....how quickly will sign up
va contract....ignite...exponential increase in sales (final stages)
will discuss...will forecast how olaregen' willdo
how big is this?....billions and billions of $s...
other...regentys...approval on the way...applicator to apply the liquid...infected area...heals it...very confident....a lot of work to do....could be a
blockbuster for us....20 to 30 % of ones not receiving treatment now
m and a strategy....explain....
many more to acquire...auditing many more...hospital...direct to patient, lab network, several other business...big pharma, hospital, clinics, doctors and patient...end to end....new treatment paradigm....
long way to go....15 % have been done....large enterprise and a large pharmaceutical company...
hospital network acquisition....add pharmacy, add clinics and ancillary products....control the revenue....vertically integrated model
how to finance acquisition?
businesses have bought into the model....scientists, everyone want to make money....BABIES....want to trust who they put the baby with..team..1-model works....2-bought into the model....3-believe in building value b4 raising money ...
no stocks for companies yet....once we derive all the value....we can go to equity market....now we own
haven't given any body any stocks (1 small exception for a diagnostic com)....
very creative with promissory notes guaranteed by moscato....
non diluting from equity market....
milestone b4 equity market....acquire everything we set to acquire...don't want to do PIPES...more acquisitions....smart...best terms
at least a year out?....no next 2 to 3 months could be sooner...between audits, regulatory legal work....bottle neck....
milestone payments, obligation based on success....they trusted us with their babies
how much planning to raise...depends on acquisitions...varies tremendously...
50,000,000 once we close everything.....cap off at 70 to 75 mil shares....now 60 mil out, 34 mil in the coffers, factored into the market...
clinical stage asset....what's happening
many assets taken over....antigen express....reconstitute these assets with Merck...triple negate...comb study...29 patients...ae37 works fantastically highly positive data...Merck saw and decided we can collaborate....as well a prostate cancer to a Chinese bio....they will do trial in Europe...stage 2...we get the data...we use for the rest of the work...pretty exciting...other cancers....
big plan with a and e...30 to 60 days...shell providers...acquire and merge...public vehicle...rights offering to the generex owners and dividend to shareholders....
shareholders approved these moves....will work for shareholders....working hard...all cylinders....
how do u generate the deal flow for these acquisitions....many companies...many come to us....the team, medical, pharmaceutical...some looking for partners, for money....they hear our model...they want to be a part of this model...
RECAP: investors should keep their eyes on what?
...
new acquisitions in the next few weeks and months
build our mso into the other states....substantial and exponential sales
ancillary services and products...we can move thru this mso...
spinoff of nugenerex oncology.....
infancy....inquisitional strategy, plans to spin off antigen
we will get all done...
last questions....top 3 reasons why investors should buy gnbt...
1...do dd, talk to investment adviser
2...big accomplishment this year and look forward to bigger accomplishment
3....value coming in is value going our....good for investor
good opportunity...
happy birthday Joe...turning 21, again...stock is up...birthday present....
path is paved with execution....
---Transformation, revenue generating assets
---up to date, explain the new business model
---jan 17, cleaned company, clean security structure
acquisitions, 2nd year....a+e....keytruda, shengzen (rights to china only)
viable company, inquisitional strategy....nugenerex distribution solutions....
names all....a lab, pharmacy network,mso, other assets
---grow to 24 more states, by year end, or 18 months
---billion dollar in revenue from veneto assets
---2 surgical businesses.....will move thru own own mso
---regenerative medicine companies, 2 olaregen, regentys
---olaregen...17 approved medical uses, sales will start in feb...
will move this product to our mso....
no longer a biotech....what is the business model
change of name is coming up down the pike
will acquire many other companies....some will close in the next couple of weeks
---revenue generating companies
veneto operation....how much in revenue?....explain...
pharmacy network....plus mso
terry anderson...medco original owner
i in Texas....working hard to make inroad into 27 more states
growth trajectory....yes he did say a 30 billion dollar venture (
generating right now....78,000,000 top line, 30 mill net....re configuring from a private to a public strategy....knee deep in building
expand to 30 states....goal....as many we can this year
can generate 1 billion per year in sales...
with pharmacy....no less than 1 billion
bottom line...100,000,000 ebitda at least
fantastic, highly profitable
other operations....picked up 2
olaregen...wound care company
17 fda approved types of wounds
ready to commercialize, will start feb...real sales, real $s
projections?....how quickly will sign up
va contract....ignite...exponential increase in sales (final stages)
will discuss...will forecast how olaregen' willdo
how big is this?....billions and billions of $s...
other...regentys...approval on the way...applicator to apply the liquid...infected area...heals it...very confident....a lot of work to do....could be a
blockbuster for us....20 to 30 % of ones not receiving treatment now
m and a strategy....explain....
many more to acquire...auditing many more...hospital...direct to patient, lab network, several other business...big pharma, hospital, clinics, doctors and patient...end to end....new treatment paradigm....
long way to go....15 % have been done....large enterprise and a large pharmaceutical company...
hospital network acquisition....add pharmacy, add clinics and ancillary products....control the revenue....vertically integrated model
how to finance acquisition?
businesses have bought into the model....scientists, everyone want to make money....BABIES....want to trust who they put the baby with..team..1-model works....2-bought into the model....3-believe in building value b4 raising money ...
no stocks for companies yet....once we derive all the value....we can go to equity market....now we own
haven't given any body any stocks (1 small exception for a diagnostic com)....
very creative with promissory notes guaranteed by moscato....
non diluting from equity market....
milestone b4 equity market....acquire everything we set to acquire...don't want to do PIPES...more acquisitions....smart...best terms
at least a year out?....no next 2 to 3 months could be sooner...between audits, regulatory legal work....bottle neck....
milestone payments, obligation based on success....they trusted us with their babies
how much planning to raise...depends on acquisitions...varies tremendously...
50,000,000 once we close everything.....cap off at 70 to 75 mil shares....now 60 mil out, 34 mil in the coffers, factored into the market...
clinical stage asset....what's happening
many assets taken over....antigen express....reconstitute these assets with Merck...triple negate...comb study...29 patients...ae37 works fantastically highly positive data...Merck saw and decided we can collaborate....as well a prostate cancer to a Chinese bio....they will do trial in Europe...stage 2...we get the data...we use for the rest of the work...pretty exciting...other cancers....
big plan with a and e...30 to 60 days...shell providers...acquire and merge...public vehicle...rights offering to the generex owners and dividend to shareholders....
shareholders approved these moves....will work for shareholders....working hard...all cylinders....
how do u generate the deal flow for these acquisitions....many companies...many come to us....the team, medical, pharmaceutical...some looking for partners, for money....they hear our model...they want to be a part of this model...
RECAP: investors should keep their eyes on what?
...
new acquisitions in the next few weeks and months
build our mso into the other states....substantial and exponential sales
ancillary services and products...we can move thru this mso...
spinoff of nugenerex oncology.....
infancy....inquisitional strategy, plans to spin off antigen
we will get all done...
last questions....top 3 reasons why investors should buy gnbt...
1...do dd, talk to investment adviser
2...big accomplishment this year and look forward to bigger accomplishment
3....value coming in is value going our....good for investor
good opportunity...
happy birthday Joe...turning 21, again...stock is up...birthday present....
path is paved with execution....
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼